Beyond THC and CBD (3/3)

Welcome to the Final Post of Our Cannabinoid Series!

If you’ve been following along, you’ve learned a lot about the foundational cannabinoids like THC and CBD, as well as some of the fascinating minor cannabinoids that add depth to the cannabis experience. In this final installment, we’ll explore the acidic forms of cannabinoids, how cannabinoids work together to create a unique experience through the entourage effect, and why cannabinoid diversity is essential to fully understanding and appreciating cannabis.

Acidic Cannabinoids: The Raw Form

Before cannabinoids like THC and CBD are exposed to heat, they exist in their acidic forms:

  • THCA (tetrahydrocannabinolic acid)
  • CBDA (cannabidiolic acid)
  • CBGA (cannabigerolic acid)

These compounds are non-intoxicating and naturally present in raw cannabis. Through a process called decarboxylation—which occurs when cannabis is heated—they convert into their more familiar forms.

While acidic cannabinoids don’t produce the same effects as their heated counterparts, they play an important role in the plant’s lifecycle and overall chemical makeup.

How Cannabinoids Work Together

Cannabis is more than the sum of its parts. Cannabinoids don’t exist in isolation—they work together, alongside terpenes, flavonoids, and other plant compounds, to create what researchers call the entourage effect

.

As mentioned in our previous blog post, THC+CBD = Entourage Effect, this concept suggests that cannabinoids may influence one another’s activity when consumed together. For example, CBD can moderate the psychoactive effects of THC, potentially reducing anxiety or paranoia that can occur with higher doses of THC. Similarly, other minor cannabinoids may contribute subtle characteristics to the overall consumer experience.

Takeaway: Rather than one compound determining the effects, it’s the combination of cannabinoids—and their relative ratios—that makes each cannabis cultivar unique.

Why Cannabinoid Diversity Matters

The presence of so many cannabinoids helps explain why different cannabis products can feel so different, even when THC percentages are similar. Two products with the same THC content may produce noticeably different effects due to variations in minor cannabinoids and terpenes.

This diversity also highlights why cannabis labeling has expanded beyond a single number. Today, many consumers look for full-spectrum or broad-spectrum products that reflect a wider range of the plant’s natural compounds.

Understanding cannabinoids empowers consumers to make more informed choices based on their preferences, lifestyle, and experience level.

The Future of Cannabinoid Research

Despite growing interest, research into cannabinoids is still in its early stages. THC and CBD dominate existing studies, but scientists are increasingly exploring lesser-known cannabinoids to better understand how they interact with the body.

As research evolves and regulations continue to change, we’re likely to see more refined discussions around cannabinoid profiles, plant genetics, and formulation techniques. This deeper knowledge may also influence how cannabis is cultivated, processed, and categorized in the future.

A Complex Plant Worth Exploring

Cannabis is often simplified in popular conversation, but its chemistry tells a different story. With over 100 naturally occurring cannabinoids—each interacting differently with the body—the plant is far more nuanced than just THC or CBD.

Whether you’re new to cannabis or have years of experience, understanding cannabinoids as a whole system—and appreciating their diversity—opens up a richer, more personalized experience.

At the end of the day, it’s not about choosing the “right” cannabinoid, but about finding the right combination that works for you. Cannabis is a complex plant, and its diversity is one of its most exciting features.

So keep exploring—whether through research or personal experience—and discover the full spectrum of what cannabis can offer.

Stay tuned for future blogs!

Written by: Emily Croes, Budtender

References:

  • Walsh, Kenneth B., et al. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in Pharmacology, vol. 12, 29 Nov. 2021, article 777804, doi:10.3389/fphar.2021.777804. PubMed Central, PMC8669157. https://pmc.ncbi.nlm.nih.gov/articles/PMC8669157/ 
  • Russo, Ethan B. Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects. British Journal of Pharmacology, vol. 163, no. 7, Aug. 2011, pp. 1344–1364, doi:10.1111/j.1476-5381.2011.01238.x. PubMed Central, PMC3165946. https://pmc.ncbi.nlm.nih.gov/articles/PMC3165946/

Posts your might like